Physician profile
Diane Sobkowicz
NPI 1285739698
$1,608.28
in general payments reported to CMS, 2019-2025
9 companies · $62.01 in 2025
The $62.01 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $556 · 2020: $334 · 2021: $193 · 2022: $249 · 2023: $155 · 2024: $59.40 · 2025: $62.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $276.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $598.09 | 2019-2023 | Assurity |
| Amgen INC. | $251.76 | 2019-2023 | Repatha |
| Novartis Pharmaceuticals Corporation | $248.77 | 2022 | |
| Medtronic, INC. | $191.78 | 2021-2025 | Cobalt Dr Mri Surescan, Linq II |
| Sanofi-Aventis U.S. LLC | $100.22 | 2019 | |
| Boston Scientific Corporation | $96.24 | 2021-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx |
| Amarin Pharma, INC. | $48.95 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $38.12 | 2019-2020 | |
| Medtronic Vascular, INC. | $34.35 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diane Sobkowicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.